• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 1-5, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 1-5, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/1/10Silver Spring, MDMike Taylor, Stephen Sundlof, Ralph Tyler, Barbara Schneeman, Jessica Leighton, Michael Landa, Andrew Zajac, Kristy MoranMichael Jacobson (Center for Science in the Public Interest); Barry Dickinson (American Medical Association); Stephen Havas (American Public Health Association); Walter Willett (Harvard School of Public Health); David Schab (Columbia University); Shula Edelkind (Feingold Association); Julie Salz Greenstein (Center for Science in the Public Interest)Sodium/Trans Fat
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/1/10Silver Spring, MDMike Taylor, Stephen Sundlof, Ralph Tyler, Jessica Leighton, Michael Landa, Andrew Zajac, Kristy MoranMichael Jacobson (Center for Science in the Public Interest) David Schab (Columbia University); Shula Edelkind (Feingold Association); Julie Salz Greenstein (Center for Science in the Public Interest)Food Dyes
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/2/10Silver Spring, MDJoshua Sharfstein, Janet Woodcock, Gerald Dal Pan, John Jenkins, Ann Witt, Jeff O’Neill Moncef Slaoui, Ellen Strahlman, Murray Stewart, Paul Huckle (GlaxoSmithKline)Cardiovascular Safety of Rosiglitazone
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/2/10Silver Spring, MDJoshua Sharfstein, Janet Woodcock, Gerald Dal Pan, John Jenkins, Ann Witt, Jeff O’NeillSteven Nissen (Cleveland Clinic Lerner School of Medicine)Cardiovascular Safety of Rosiglitazone
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/3/10Washington, DCN/AEllen Sigal (Friends of Cancer Research); Francis Collins (National Institutes of Health); Congressman Dingell, Senator Stevens, Senator InouyeSpeech at Friends of Cancer Research Honoree Reception
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/4/10Washington, DCMolly Muldoon, Meghan ScottN/ASpeech at the Atlantic’s Inaugural Food Summit
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs3/5/10Washington, DCWilliam Flynn, Jeanne Ireland, Gerie VossStaff of Senator Dianne Feinstein and Congressman Louise SlaughterAntimicrobial Resistance
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/2/10Washington, DCWilliam Flynn, Dave WhiteN/AUnited States Animal Health Association and the American Association of Veterinary Laboratory Diagnosticians Annual Committee on Government Relations Meeting
Beth Martino, Associate Commissioner for External Affairs3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/4/10Silver Spring, MDSharon Mayl, Dianne Murphy, Robert Nelson, Benson Silverman, Sue Anderson, Catherine Copp, Jeanne Ireland, Paula TrumboRoberta Downing, Zoe Neuberger (Center for Budget and Policy Priorities); Douglas Greenaway (National WIC Association); Meredith McGehee (California WIC Association); Kristen Mizzi, Cindy Pellegrini (American Academy of Pediatrics)Infant Formula
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/4/10Silver Spring, MDLynne Rice, John McCrohanSophia Parker  (DSFederal, Inc.)Medical Devices
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/1/10-
3/5/10
Washington, DCAmy Hertz, Kim ElliottDr. Fineberg, Dr. Salerno (Institute of Medicine)Meet and Greet
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Russell Abbott, Deputy Commissioner for Administration3/1/10-
3/5/10
N/AN/AN/ANo Significant Meetings
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition3/3/10Washington, DCN/AN/AFood Safety Action Day
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/1/10-
3/3/10
Stockholm, SwedenN/AN/A7th Global College of Neuroprotection & Neurogeneration Conference